DUAVEE

In May 2020, the Company initiated a global voluntary recall of Duavee in order to make packaging updates and ensure product stability throughout its shelf life. It is important to note that this recall was solely related to a packaging issue and not due to any concerns regarding the efficacy or safety of the product.

Duavee is now available again! Please review the complete Prescribing Information, which includes a BOXED WARNING and Patient Information.

No, there is currently no generic version of Duavee available in the United States. It is important to be cautious of fraudulent online pharmacies that may try to sell illegal generic versions of Duavee. These medications could be counterfeit and potentially harmful.

Bazedoxifene is not a hormone, but it functions as a selective estrogen receptor modulator (SERM) in certain areas of the body. It helps to maintain bone density and lowers the risk of uterine cancer associated with estrogen use.

Bazedoxifene is classified as a selective estrogen receptor modulator (SERM) medication.

Fezolinetant (Veozah) was approved by the FDA in May 2023. This groundbreaking drug is the first of its kind, specifically developed to alleviate the frequency and intensity of flushing and sweating episodes that women experience when their estrogen levels decline.

DUAVEE is a medication that combines conjugated estrogens with bazedoxifene, which acts as both an estrogen agonist and antagonist.

Weight gain and loss are not listed as side effects of Duavee, and clinical studies of the drug did not show any significant weight changes. However, it is important to note that unexplained weight loss could potentially be a symptom of cancer. Additionally, taking Duavee may increase the risk of developing certain types of cancer, such as endometrial, ovarian, and breast cancer.

If you experience any of the following serious side effects, it is important to notify your doctor immediately: persistent nausea or vomiting, breast lumps, changes in mental or mood such as depression or memory loss, severe stomach or abdominal pain, yellowing of the eyes or skin, dark urine, swelling of the hands, ankles, or feet, increased thirst or urination, or any other unusual symptoms.

The price of a 30-tablet supply of Duavee oral tablets (20 mg-0.45 mg) can vary, but it is typically around $211, depending on the pharmacy you choose.

The active ingredients in DUAVEE are conjugated estrogens and bazedoxifene. Conjugated estrogens are a combination of sodium estrone sulfate, sodium equilin sulfate, and other components such as sodium sulfate conjugates, 17?±-dihydroequilin, 17?±-estradiol, and 17?²-dihydroequilin.

Understanding that estrogen suppresses LPL activity on fat cells is crucial. This may explain why some women experience weight gain after menopause or breast cancer treatment, which reduces estrogen levels. With lower estrogen levels, LPL is able to pull fat into fat cells and store it there.

Duavee, which is FDA-approved for alleviating hot flashes and preventing osteoporosis, is infrequently prescribed to women with a heightened risk of breast cancer due to its estrogen content. This cautionary approach is based on the association between prolonged estrogen exposure and an elevated likelihood of developing breast cancer.

It is recommended to take Duavee for the minimum duration required and only as long as necessary for treatment. It is advisable to have regular discussions with your doctor to determine if continued treatment is necessary. If you are considering using a treatment solely for the prevention of bone loss, it is recommended to consult with your doctor to determine if an alternative treatment without estrogens may be more suitable for you.

Estrogen therapy (ET) is a treatment option for menopausal symptoms. It effectively alleviates these symptoms, but it also carries a higher risk of developing endometrial cancer in women with a uterus. Therefore, ET is considered safe only for women who have undergone a hysterectomy and do not have a uterus.

No, it is not necessary to take a progesterone with Duavee (conjugated estrogens / bazedoxifene).

If you are having difficulties accessing the PDF files below due to disabilities, please contact us at (301) 796-3634 for assistance. The approval date for these files is 10/3/2013.

DUAVEE is a medication that is taken once a day to alleviate moderate to severe hot flashes caused by menopause. It is available in the form of a tablet and can be consumed with or without food.

Although some claim that estrogen creams, sprays, and gels are safer than the pill form, there is insufficient evidence to support this assertion. Additionally, it is important to note that these alternatives still pose the same risks of cancer and stroke.

Duavive is a medication prescribed to alleviate symptoms, such as hot flushes, that are a result of decreased levels of the female hormone estrogen in women who have undergone menopause.

In October 2013, the U.S. Food and Drug Administration (FDA) granted approval to Duavee for the treatment of moderate-to-severe vasomotor symptoms (hot flashes) related to menopause and the prevention of postmenopausal osteoporosis.

Some of the less serious but frequently experienced side effects of Duavee include muscle spasms, nausea, diarrhea, and upset stomach.

Duavee is a medication that contains a combination of conjugated estrogens and bazedoxifene, which is a selective estrogen receptor modulator. Bazedoxifene has the ability to activate estrogen receptors in bone tissue, while also acting as an antagonist in the breast and uterus.

For women with a uterus, this medication is a blend of conjugated estrogens and bazedoxifene (an estrogen agonist/antagonist) that is utilized to alleviate menopausal symptoms (such as hot flashes and vaginal dryness) and to prevent osteoporosis (bone loss) following menopause.

It is not recommended for women over 75 years of age to use DUAVEE (conjugated estrogens/bazedoxifene) tablets, 0.45 mg/20 mg. These tablets are oval, biconvex, and pink in color. They are branded with the imprint “0.45/20” in black ink on one side.

HRT frequently enhances energy levels, leading to increased motivation for physical activity and enjoyment of exercise. Consequently, weight management can be significantly improved.

No, it is not necessary to take a progesterone with Duavee (conjugated estrogens / bazedoxifene).

Duavee is prescribed to women who have reached menopause and have a uterus. It is used to alleviate moderate to severe hot flashes and also to lower the risk of developing osteoporosis, a condition characterized by brittle and fragile bones.

There is limited evidence suggesting that most forms of HRT contribute to weight gain. However, it is common to experience weight gain during menopause and as you age, regardless of whether you are on HRT or not. To manage your weight, it is recommended to engage in regular exercise and maintain a balanced diet.

Estrogen therapy has the ability to slow down the aging process of the skin, leading to a more youthful appearance. Hormone replacement therapy (HRT) enhances skin elasticity, thickness, collagen, and water content, all of which contribute to a more youthful and improved skin appearance.

Duavee is intended for women who have undergone menopause and still have a uterus. Clinical trials lasting 1-2 years have shown that Duavee effectively enhances bone mineral density in the lumbar spine and total hip, thereby reducing the risk of postmenopausal osteoporosis.